Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy and Thymalfasin in Metastatic Colorectal Cancer
NCT02535988Phase 2Withdrawn
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Peptides
01
Overview
A Phase 2 trial of thymosin alpha 1 in metastatic colorectal cancer (mCRC), sponsored by Zhejiang Provincial People's Hospital. Planned start Sep 2015; status: withdrawn.
02
Drugs
thymosin alpha 1
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02535988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535988.